Antithrombotic And Thrombolytic Therapy For Valvular Disease

Publication Date: February 1, 2012
Last Updated: March 14, 2022

Recommendations

Rheumatic Mitral Valve Disease

In patients with rheumatic mitral valve disease and normal sinus rhythm with a left atrial diameter <55 mm, we suggest not using antiplatelet or VKA therapy. (2, C)
307795

Overview

Title

Antithrombotic And Thrombolytic Therapy For Valvular Disease

Authoring Organization